Ticker Scorecard - ATAI Basics Company: Atai Life Sciences N.V. IPO Date: June 18, 2021 Sector: Healthcare Industry: Biotechnology Market Cap: $271.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.78% Avg Daily Range (30 D): $0.09 | 4.55% Avg Daily Range (90 D): $0.08 | 4.89% Institutional Daily Volume Avg Daily Volume: 1.02M Avg Daily Volume (30 D): 3.24M Avg Daily Volume (90 D): 2.41M Trade Size Avg Trade Size (Sh.): 200 Avg Trade Size (Sh.) (30 D): 328 Avg Trade Size (Sh.) (90 D): 308 Institutional Trades Total Inst.Trades: 101 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $.91M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .32M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.07M Avg Closing Trade (30 D): $.91M Avg Closing Trade (90 D): $.93M Avg Closing Volume: 666.56K     News Feb 25, 2025 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Feb 13, 2025 @ 3:47 AM atai Life Sciences Announces Pricing of Public Off... Source: N/A Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight Aug 6, 2024 @ 7:13 PM 4 Psychedelic Stocks to Consider as Clinical Trial... Source: Professor Ari Zoldan Jun 26, 2024 @ 11:00 AM atai Life Sciences to Participate in the H.C. Wain... Source: atai Life Sciences Financials   TTM Q4 2024 FY 2024 Basic EPS $-.93 $-.24 $-.93 Diluted EPS $-.93 $-.24 $-.93 Revenue $ .31M $ -.01M $ .31M Gross Profit $ $ $ Net Income / Loss $ -150.05M $ -38.99M $ -150.05M Operating Income / Loss $ -102.69M $ -30.27M $ -102.69M Cost of Revenue $ $ $ Net Cash Flow $ -17.89M $ -17.58M $ -17.89M PE Ratio